Celgene Restructures Jounce Alliance Amid BMS Acquisition

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 8 (Table of Contents)

Published: 1 Aug-2019

DOI: 10.3833/pdr.v2019.i8.2445     ISSN: 1756-7874

Section: Licensing



As its acquisition by Bristol-Myers Squibb (BMS) is underway, Celgene has agreed to restructure its July 2016 collaboration with Jounce Therapeutics...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details